4,161 HCA Healthcare, Inc. $HCA Shares Purchased by Assenagon Asset Management S.A.

Key Points

• Assenagon Asset Management increased its HCA Healthcare stake by 27.7% in the third quarter, purchasing 4,161 additional shares and bringing its holdings to 19,162 shares valued at approximately $8.18 million.
• Institutional investors own 62.73% of HCA Healthcare, with major firms including BlackRock, Wellington Management and Bank of America among recent buyers.
• HCA reported quarterly revenue of $20.23 billion and EPS of $7.59, exceeding analyst estimates, while analysts maintain a consensus “Moderate Buy” rating with a $467.61 price target.

Assenagon Asset Management S.A. lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 27.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,162 shares of the company's stock after buying an additional 4,161 shares during the period. Assenagon Asset Management S.A.'s holdings in HCA Healthcare were worth $8,177,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the business. BlackRock Inc. bought a new position in shares of HCA Healthcare during the 2nd quarter valued at $5,069,974,000. Legal & General Group Plc purchased a new position in shares of HCA Healthcare in the 2nd quarter worth $410,992,000. Jupiter Topco LLC bought a new stake in shares of HCA Healthcare in the second quarter worth $371,138,000. Wellington Management Group LLP increased its position in HCA Healthcare by 20.5% during the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company's stock valued at $1,835,397,000 after acquiring an additional 799,761 shares during the last quarter. Finally, Bank of America Corp DE bought a new position in HCA Healthcare in the second quarter valued at about $238,457,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Trading Down 0.7%

NYSE HCA opened at $455.53 on Tuesday. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The company's 50 day moving average is $427.22 and its two-hundred day moving average is $418.81. The stock has a market cap of $98.62 billion, a price-to-earnings ratio of 15.44, a PEG ratio of 1.55 and a beta of 1.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The business's revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the business earned $6.84 earnings per share. Sell-side analysts forecast that HCA Healthcare, Inc. will post 29.45 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th were issued a $0.78 dividend. The ex-dividend date of this dividend was Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's payout ratio is currently 10.45%.

Wall Street Analyst Weigh In

HCA has been the topic of several research reports. Sanford C. Bernstein reissued a "market perform" rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Mizuho reduced their price target on shares of HCA Healthcare from $525.00 to $475.00 and set an "outperform" rating for the company in a research report on Tuesday, July 28th. Truist Financial lowered their price objective on shares of HCA Healthcare from $535.00 to $495.00 and set a "buy" rating on the stock in a research note on Monday, July 27th. The Goldman Sachs Group dropped their price objective on shares of HCA Healthcare from $558.00 to $485.00 and set a "buy" rating on the stock in a report on Tuesday, July 28th. Finally, Morgan Stanley cut their target price on shares of HCA Healthcare from $425.00 to $380.00 and set an "underweight" rating for the company in a research report on Monday, July 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $467.61.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women's and children's services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.